Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy.
Aged
Aged, 80 and over
Area Under Curve
Carcinoma, Non-Small-Cell Lung
/ diagnostic imaging
Female
Humans
Logistic Models
Lung Neoplasms
/ diagnostic imaging
Male
Middle Aged
Models, Theoretical
Radiation Pneumonitis
/ diagnostic imaging
Radiosurgery
/ adverse effects
Radiotherapy Planning, Computer-Assisted
Tomography, X-Ray Computed
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
24 11 2020
24 11 2020
Historique:
received:
06
05
2020
accepted:
10
11
2020
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
25
3
2021
Statut:
epublish
Résumé
This study developed a radiomics-based predictive model for radiation-induced pneumonitis (RP) after lung cancer stereotactic body radiation therapy (SBRT) on pretreatment planning computed tomography (CT) images. For the RP prediction models, 275 non-small-cell lung cancer patients consisted of 245 training (22 with grade ≥ 2 RP) and 30 test cases (8 with grade ≥ 2 RP) were selected. A total of 486 radiomic features were calculated to quantify the RP texture patterns reflecting radiation-induced tissue reaction within lung volumes irradiated with more than x Gy, which were defined as LVx. Ten subsets consisting of all 22 RP cases and 22 or 23 randomly selected non-RP cases were created from the imbalanced dataset of 245 training patients. For each subset, signatures were constructed, and predictive models were built using the least absolute shrinkage and selection operator logistic regression. An ensemble averaging model was built by averaging the RP probabilities of the 10 models. The best model areas under the receiver operating characteristic curves (AUCs) calculated on the training and test cohort for LV5 were 0.871 and 0.756, respectively. The radiomic features calculated on pretreatment planning CT images could be predictive imaging biomarkers for RP after lung cancer SBRT.
Identifiants
pubmed: 33235324
doi: 10.1038/s41598-020-77552-7
pii: 10.1038/s41598-020-77552-7
pmc: PMC7686358
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20424Références
Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):323-9
pubmed: 10487552
Radiother Oncol. 2019 Apr;133:106-112
pubmed: 30935565
BMC Res Notes. 2016 Mar 08;9:147
pubmed: 26951763
Radiat Oncol. 2010 May 09;5:32
pubmed: 20459699
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8
pubmed: 20638194
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
Clin Lung Cancer. 2017 Nov;18(6):e425-e431
pubmed: 28623121
Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):110-5
pubmed: 12504042
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1427-31
pubmed: 16169670
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):444-50
pubmed: 22682812
Chest. 2003 Nov;124(5):1946-55
pubmed: 14605072
Med Phys. 2018 Nov;45(11):5116-5128
pubmed: 30230556
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1355-63
pubmed: 15817337
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1048-56
pubmed: 25670540
Phys Med Biol. 2015 Jul 21;60(14):5471-96
pubmed: 26119045
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1143-1158
pubmed: 30170872
World J Radiol. 2014 Sep 28;6(9):708-15
pubmed: 25276313
Chest. 2004 Jan;125(1):340-4
pubmed: 14718465
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S70-6
pubmed: 20171521
Med Phys. 2019 May;46(5):2497-2511
pubmed: 30891794